Red Blood Cell Contamination of the Final Cell Product Impairs the Efficacy of Autologous Bone Marrow Mononuclear Cell Therapy
Objectives The aim of this study was to identify an association between the quality and functional activity of bone marrow-derived progenitor cells (BMCs) used for cardiovascular regenerative therapies and contractile recovery in patients with acute myocardial infarction included in the placebo-cont...
Saved in:
Published in | Journal of the American College of Cardiology Vol. 55; no. 13; pp. 1385 - 1394 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
30.03.2010
Elsevier Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objectives The aim of this study was to identify an association between the quality and functional activity of bone marrow-derived progenitor cells (BMCs) used for cardiovascular regenerative therapies and contractile recovery in patients with acute myocardial infarction included in the placebo-controlled REPAIR-AMI (Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction) trial. Background Isolation procedures of autologous BMCs might affect cell functionality and therapeutic efficacy. Methods Quality of cell isolation was assessed by measuring the total number of isolated BMCs, CD34+ and CD133+ cells, their colony-forming unit (CFU) and invasion capacity, cell viability, and contamination of the final BMC preparation with thrombocytes and red blood cells (RBCs). Results The number of RBCs contaminating the final cell product significantly correlated with reduced recovery of left ventricular ejection fraction 4 months after BMC therapy (p = 0.007). Higher numbers of RBCs in the BMC preparation were associated with reduced BMC viability (r = −0.23, p = 0.001), CFU capacity (r = −0.16, p = 0.03), and invasion capacity (r = −0.27, p < 0.001). To assess a causal role for RBC contamination, we coincubated isolated BMCs with RBCs for 24 h in vitro. The addition of RBCs dose-dependently abrogated migratory capacity (p = 0.003) and reduced CFU capacity (p < 0.05) of isolated BMCs. Neovascularization capacity was significantly impaired after infusion of BMCs contaminated with RBCs, compared with BMCs alone (p < 0.05). Mechanistically, the addition of RBCs was associated with a profound reduction in mitochondrial membrane potential of BMCs. Conclusions Contaminating RBCs affects the functionality of isolated BMCs and determines the extent of left ventricular ejection fraction recovery after intracoronary BMC infusion in patients with acute myocardial infarction. These results suggest a bioactivity response relationship very much like a dose–response relationship in drug trials. (Reinfusion of Enriched Progenitor cells and Infarct Remodeling in Acute Myocardial Infarction [REPAIR-AMI]; NCT00279175 ) |
---|---|
AbstractList | OBJECTIVESThe aim of this study was to identify an association between the quality and functional activity of bone marrow-derived progenitor cells (BMCs) used for cardiovascular regenerative therapies and contractile recovery in patients with acute myocardial infarction included in the placebo-controlled REPAIR-AMI (Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction) trial.BACKGROUNDIsolation procedures of autologous BMCs might affect cell functionality and therapeutic efficacy.METHODSQuality of cell isolation was assessed by measuring the total number of isolated BMCs, CD34+ and CD133+ cells, their colony-forming unit (CFU) and invasion capacity, cell viability, and contamination of the final BMC preparation with thrombocytes and red blood cells (RBCs).RESULTSThe number of RBCs contaminating the final cell product significantly correlated with reduced recovery of left ventricular ejection fraction 4 months after BMC therapy (p = 0.007). Higher numbers of RBCs in the BMC preparation were associated with reduced BMC viability (r = -0.23, p = 0.001), CFU capacity (r = -0.16, p = 0.03), and invasion capacity (r = -0.27, p < 0.001). To assess a causal role for RBC contamination, we coincubated isolated BMCs with RBCs for 24 h in vitro. The addition of RBCs dose-dependently abrogated migratory capacity (p = 0.003) and reduced CFU capacity (p < 0.05) of isolated BMCs. Neovascularization capacity was significantly impaired after infusion of BMCs contaminated with RBCs, compared with BMCs alone (p < 0.05). Mechanistically, the addition of RBCs was associated with a profound reduction in mitochondrial membrane potential of BMCs.CONCLUSIONSContaminating RBCs affects the functionality of isolated BMCs and determines the extent of left ventricular ejection fraction recovery after intracoronary BMC infusion in patients with acute myocardial infarction. These results suggest a bioactivity response relationship very much like a dose-response relationship in drug trials. (Reinfusion of Enriched Progenitor cells and Infarct Remodeling in Acute Myocardial Infarction [REPAIR-AMI]; NCT00279175). The aim of this study was to identify an association between the quality and functional activity of bone marrow-derived progenitor cells (BMCs) used for cardiovascular regenerative therapies and contractile recovery in patients with acute myocardial infarction included in the placebo-controlled REPAIR-AMI (Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction) trial. Isolation procedures of autologous BMCs might affect cell functionality and therapeutic efficacy. Quality of cell isolation was assessed by measuring the total number of isolated BMCs, CD34+ and CD133+ cells, their colony-forming unit (CFU) and invasion capacity, cell viability, and contamination of the final BMC preparation with thrombocytes and red blood cells (RBCs). The number of RBCs contaminating the final cell product significantly correlated with reduced recovery of left ventricular ejection fraction 4 months after BMC therapy (p = 0.007). Higher numbers of RBCs in the BMC preparation were associated with reduced BMC viability (r = -0.23, p = 0.001), CFU capacity (r = -0.16, p = 0.03), and invasion capacity (r = -0.27, p < 0.001). To assess a causal role for RBC contamination, we coincubated isolated BMCs with RBCs for 24 h in vitro. The addition of RBCs dose-dependently abrogated migratory capacity (p = 0.003) and reduced CFU capacity (p < 0.05) of isolated BMCs. Neovascularization capacity was significantly impaired after infusion of BMCs contaminated with RBCs, compared with BMCs alone (p < 0.05). Mechanistically, the addition of RBCs was associated with a profound reduction in mitochondrial membrane potential of BMCs. Contaminating RBCs affects the functionality of isolated BMCs and determines the extent of left ventricular ejection fraction recovery after intracoronary BMC infusion in patients with acute myocardial infarction. These results suggest a bioactivity response relationship very much like a dose-response relationship in drug trials. (Reinfusion of Enriched Progenitor cells and Infarct Remodeling in Acute Myocardial Infarction [REPAIR-AMI]; NCT00279175). Objectives The aim of this study was to identify an association between the quality and functional activity of bone marrow-derived progenitor cells (BMCs) used for cardiovascular regenerative therapies and contractile recovery in patients with acute myocardial infarction included in the placebo-controlled REPAIR-AMI (Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction) trial. Background Isolation procedures of autologous BMCs might affect cell functionality and therapeutic efficacy. Methods Quality of cell isolation was assessed by measuring the total number of isolated BMCs, CD34+ and CD133+ cells, their colony-forming unit (CFU) and invasion capacity, cell viability, and contamination of the final BMC preparation with thrombocytes and red blood cells (RBCs). Results The number of RBCs contaminating the final cell product significantly correlated with reduced recovery of left ventricular ejection fraction 4 months after BMC therapy (p = 0.007). Higher numbers of RBCs in the BMC preparation were associated with reduced BMC viability (r = -0.23, p = 0.001), CFU capacity (r = -0.16, p = 0.03), and invasion capacity (r = -0.27, p < 0.001). To assess a causal role for RBC contamination, we coincubated isolated BMCs with RBCs for 24 h in vitro. The addition of RBCs dose-dependently abrogated migratory capacity (p = 0.003) and reduced CFU capacity (p < 0.05) of isolated BMCs. Neovascularization capacity was significantly impaired after infusion of BMCs contaminated with RBCs, compared with BMCs alone (p < 0.05). Mechanistically, the addition of RBCs was associated with a profound reduction in mitochondrial membrane potential of BMCs. Conclusions Contaminating RBCs affects the functionality of isolated BMCs and determines the extent of left ventricular ejection fraction recovery after intracoronary BMC infusion in patients with acute myocardial infarction. These results suggest a bioactivity response relationship very much like a dose-response relationship in drug trials. (Reinfusion of Enriched Progenitor cells and Infarct Remodeling in Acute Myocardial Infarction [REPAIR-AMI];NCT00279175) Objectives The aim of this study was to identify an association between the quality and functional activity of bone marrow-derived progenitor cells (BMCs) used for cardiovascular regenerative therapies and contractile recovery in patients with acute myocardial infarction included in the placebo-controlled REPAIR-AMI (Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction) trial. Background Isolation procedures of autologous BMCs might affect cell functionality and therapeutic efficacy. Methods Quality of cell isolation was assessed by measuring the total number of isolated BMCs, CD34+ and CD133+ cells, their colony-forming unit (CFU) and invasion capacity, cell viability, and contamination of the final BMC preparation with thrombocytes and red blood cells (RBCs). Results The number of RBCs contaminating the final cell product significantly correlated with reduced recovery of left ventricular ejection fraction 4 months after BMC therapy (p = 0.007). Higher numbers of RBCs in the BMC preparation were associated with reduced BMC viability (r = −0.23, p = 0.001), CFU capacity (r = −0.16, p = 0.03), and invasion capacity (r = −0.27, p < 0.001). To assess a causal role for RBC contamination, we coincubated isolated BMCs with RBCs for 24 h in vitro. The addition of RBCs dose-dependently abrogated migratory capacity (p = 0.003) and reduced CFU capacity (p < 0.05) of isolated BMCs. Neovascularization capacity was significantly impaired after infusion of BMCs contaminated with RBCs, compared with BMCs alone (p < 0.05). Mechanistically, the addition of RBCs was associated with a profound reduction in mitochondrial membrane potential of BMCs. Conclusions Contaminating RBCs affects the functionality of isolated BMCs and determines the extent of left ventricular ejection fraction recovery after intracoronary BMC infusion in patients with acute myocardial infarction. These results suggest a bioactivity response relationship very much like a dose–response relationship in drug trials. (Reinfusion of Enriched Progenitor cells and Infarct Remodeling in Acute Myocardial Infarction [REPAIR-AMI]; NCT00279175 ) The aim of this study was to identify an association between the quality and functional activity of bone marrow-derived progenitor cells (BMCs) used for cardiovascular regenerative therapies and contractile recovery in patients with acute myocardial infarction included in the placebo-controlled REPAIR-AMI (Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction) trial. Isolation procedures of autologous BMCs might affect cell functionality and therapeutic efficacy. Quality of cell isolation was assessed by measuring the total number of isolated BMCs, CD34+ and CD133+ cells, their colony-forming unit (CFU) and invasion capacity, cell viability, and contamination of the final BMC preparation with thrombocytes and red blood cells (RBCs). The number of RBCs contaminating the final cell product significantly correlated with reduced recovery of left ventricular ejection fraction 4 months after BMC therapy (p = 0.007). Higher numbers of RBCs in the BMC preparation were associated with reduced BMC viability (r = −0.23, p = 0.001), CFU capacity (r = −0.16, p = 0.03), and invasion capacity (r = −0.27, p < 0.001). To assess a causal role for RBC contamination, we coincubated isolated BMCs with RBCs for 24 h in vitro. The addition of RBCs dose-dependently abrogated migratory capacity (p = 0.003) and reduced CFU capacity (p < 0.05) of isolated BMCs. Neovascularization capacity was significantly impaired after infusion of BMCs contaminated with RBCs, compared with BMCs alone (p < 0.05). Mechanistically, the addition of RBCs was associated with a profound reduction in mitochondrial membrane potential of BMCs. Contaminating RBCs affects the functionality of isolated BMCs and determines the extent of left ventricular ejection fraction recovery after intracoronary BMC infusion in patients with acute myocardial infarction. These results suggest a bioactivity response relationship very much like a dose–response relationship in drug trials. (Reinfusion of Enriched Progenitor cells and Infarct Remodeling in Acute Myocardial Infarction [REPAIR-AMI]; NCT00279175) |
Author | Assmus, Birgit, MD Tonn, Torsten, MD Zeiher, Andreas M., MD Dimmeler, Stefanie, PhD Yoon, Chang-Hwan, MD Leistner, David, MD Schächinger, Volker, MD Klotsche, Jens, MSc Seifried, Erhard, MD Seeger, Florian H., MD |
Author_xml | – sequence: 1 fullname: Assmus, Birgit, MD – sequence: 2 fullname: Tonn, Torsten, MD – sequence: 3 fullname: Seeger, Florian H., MD – sequence: 4 fullname: Yoon, Chang-Hwan, MD – sequence: 5 fullname: Leistner, David, MD – sequence: 6 fullname: Klotsche, Jens, MSc – sequence: 7 fullname: Schächinger, Volker, MD – sequence: 8 fullname: Seifried, Erhard, MD – sequence: 9 fullname: Zeiher, Andreas M., MD – sequence: 10 fullname: Dimmeler, Stefanie, PhD |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22635997$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20338501$$D View this record in MEDLINE/PubMed |
BookMark | eNp9klFrFDEQx4NU7LX6BXyQgIhPeyabTbILUmiPVgstitbnkMtObM7s5kx2LffSz27WPS30waeQmd8M_5n_HKGDPvSA0EtKlpRQ8W6z3GhjliUhTQ4sCW-eoAXlvC4Yb-QBWhDJeEFJIw_RUUobQoioafMMHZaEsZoTukD3X6DFZz6EFq_Ae7wK_aA71-vBhR4Hi4dbwBf57-f85xja0Qz4sttqF9Of9Lm1zmizm_DTcQg-fA9jwmdZLb7WMYY7fB2y9tF40HHuc3MLUW93z9FTq32CF_v3GH27OL9ZfSyuPn24XJ1eFYazaiiAN7WtLLeESUprIyhfV6JZU2KllpJXnNZccClb2pi6hnYNpdDSAhAtuGXsGL2d-25j-DlCGlTnkslCdA9Zq5J5H4wzKjL5-hG5CWPM8ydFORGlELWsMlXOlIkhpQhWbaPrdNwpStRkjtqoyRw1mTPFsjm56NW-9bjuoP1X8teNDLzZAzoZ7W3UvXHpgStFNraRmXs_c5BX9stBVMk46A20LoIZVBvc_3WcPCo33vXZQv8DdpAe5lWpVER9nc5ouiKaD6iUQrLfWBnCcw |
CODEN | JACCDI |
CitedBy_id | crossref_primary_10_1016_j_jns_2019_05_002 crossref_primary_10_1002_ejhf_422 crossref_primary_10_1007_s11886_014_0526_z crossref_primary_10_1016_j_jcyt_2014_12_011 crossref_primary_10_3390_bioengineering9020049 crossref_primary_10_1016_j_jcyt_2016_03_291 crossref_primary_10_1007_s00266_024_03892_8 crossref_primary_10_1111_trf_12873 crossref_primary_10_1016_j_biomaterials_2016_03_020 crossref_primary_10_1097_HCO_0000000000000156 crossref_primary_10_3109_07853890_2012_672026 crossref_primary_10_1161_CIRCRESAHA_114_303720 crossref_primary_10_1097_HCO_0b013e32834fe969 crossref_primary_10_1089_ten_tea_2014_0410 crossref_primary_10_1161_CIRCRESAHA_113_302512 crossref_primary_10_1007_s12055_018_0739_7 crossref_primary_10_1093_eurheartj_ehv592 crossref_primary_10_1093_eurheartj_ehu062 crossref_primary_10_1016_j_trsl_2013_12_005 crossref_primary_10_1007_s40011_018_0966_0 crossref_primary_10_1002_14651858_CD006536_pub4 crossref_primary_10_1007_s12265_010_9249_8 crossref_primary_10_1016_j_jvssci_2023_100130 crossref_primary_10_1186_s13287_021_02610_4 crossref_primary_10_1161_CIRCRESAHA_110_226902 crossref_primary_10_1161_CIRCULATIONAHA_114_012913 crossref_primary_10_1093_cvr_cvab270 crossref_primary_10_1186_2052_8426_1_4 crossref_primary_10_1186_scrt382 crossref_primary_10_1111_trf_13754 crossref_primary_10_1002_jssc_201600329 crossref_primary_10_1089_ten_tec_2016_0184 crossref_primary_10_1186_s12967_014_0276_0 crossref_primary_10_1111_j_1600_6143_2011_03750_x crossref_primary_10_1155_2014_235941 crossref_primary_10_33529_ANGIO2019414 crossref_primary_10_1038_nm_3778 crossref_primary_10_1016_j_ahj_2011_05_024 crossref_primary_10_1016_j_cjca_2014_03_026 crossref_primary_10_1007_s11936_010_0099_0 crossref_primary_10_1016_j_yjmcc_2010_06_010 crossref_primary_10_1016_j_jsps_2022_06_017 crossref_primary_10_1139_cjpp_2017_0742 crossref_primary_10_1016_j_ijcac_2016_04_001 crossref_primary_10_2217_fca_13_78 crossref_primary_10_1007_s12265_012_9389_0 crossref_primary_10_1093_eurheartj_ehq449 crossref_primary_10_1155_2015_762407 crossref_primary_10_1007_s00068_020_01331_2 crossref_primary_10_1007_s10557_016_6696_8 crossref_primary_10_1007_s10741_021_10082_0 crossref_primary_10_1002_stem_1649 crossref_primary_10_1016_j_jobcr_2014_11_004 crossref_primary_10_1097_CRD_0000000000000018 crossref_primary_10_5966_sctm_2011_0016 crossref_primary_10_1155_2015_135023 crossref_primary_10_1186_s13287_017_0589_z crossref_primary_10_1016_j_phrs_2017_02_015 crossref_primary_10_1016_j_tmrv_2016_03_001 crossref_primary_10_3390_bioengineering9040142 crossref_primary_10_1371_journal_pone_0237401 crossref_primary_10_1042_CBI20090211 crossref_primary_10_1093_eurheartj_ehq513 crossref_primary_10_1111_trf_15592 crossref_primary_10_1007_s00059_010_3358_7 crossref_primary_10_1186_s13287_016_0467_0 crossref_primary_10_1111_jocs_13789 crossref_primary_10_3390_ijms20194875 crossref_primary_10_1253_circj_CJ_17_0045 crossref_primary_10_1371_journal_pone_0050293 crossref_primary_10_1093_cvr_cvq301 crossref_primary_10_3346_jkms_2014_29_1_23 |
Cites_doi | 10.1111/j.2517-6161.1964.tb00553.x 10.1073/pnas.0810230105 10.1056/NEJMoa032292 10.1016/j.cell.2008.11.026 10.1038/nm948 10.1016/S0140-6736(05)67895-6 10.1073/pnas.0601026103 10.1161/CIRCULATIONAHA.105.553925 10.1001/archinte.167.10.989 10.1016/j.jacc.2006.02.003 10.1038/ncb1700 10.1097/MOH.0b013e3283043819 10.1056/NEJMoa051779 10.1161/CIRCRESAHA.108.175943 10.1161/ATVBAHA.108.174060 10.1161/01.CIR.0000095788.78169.AF 10.1038/ncpcardio1324 10.1634/stemcells.2007-0562 10.1007/s10540-007-9044-1 10.1016/j.toxlet.2005.03.004 10.1161/01.CIR.0000124476.32871.E3 10.1056/NEJMoa060186 10.1093/eurheartj/ehl509 10.1161/01.CIR.0000109141.48980.37 10.1161/01.STR.32.2.561 10.1161/ATVBAHA.107.155317 10.1056/NEJMoa030207 10.1161/hh1301.093953 10.1161/01.RES.0000264508.47717.6b 10.1038/ncpcardio0441 10.1089/scd.1.1996.5.213 10.1161/CIRCRESAHA.107.164376 10.1182/blood.V91.11.4106 10.1093/eurheartj/ehn220 10.1097/MOT.0b013e32830fdfc4 10.1093/eurheartj/ehl388 10.1016/S0140-6736(03)14232-8 |
ContentType | Journal Article |
Copyright | American College of Cardiology Foundation 2010 American College of Cardiology Foundation 2015 INIST-CNRS Copyright Elsevier Limited Mar 30, 2010 |
Copyright_xml | – notice: American College of Cardiology Foundation – notice: 2010 American College of Cardiology Foundation – notice: 2015 INIST-CNRS – notice: Copyright Elsevier Limited Mar 30, 2010 |
DBID | 6I. AAFTH IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 7TK H94 K9. NAPCQ 7X8 |
DOI | 10.1016/j.jacc.2009.10.059 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Immunology Abstracts Neurosciences Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Immunology Abstracts Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1558-3597 |
EndPage | 1394 |
ExternalDocumentID | 3243082691 10_1016_j_jacc_2009_10_059 20338501 22635997 S0735109710002767 1_s2_0_S0735109710002767 |
Genre | Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: DFG – fundername: Foundation Leducq Transatlantic Network of Excellence for Cardiac Regeneration – fundername: Guidant |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 0SF 18M 1B1 1CY 1P~ 1~. 1~5 29L 2WC 3O- 3V. 4.4 457 4G. 53G 5GY 5RE 5VS 6I. 6PF 7-5 71M 7RV 8P~ AABNK AABVL AACTN AAEDT AAEDW AAFTH AAIKJ AAKUH AALRI AAOAW AAQFI AAQQT AAQXK AAXUO AAYOK ABBQC ABFNM ABFRF ABJNI ABLJU ABMAC ABMZM ABOCM ABVKL ABXDB ACGFO ACGFS ACIUM ACJTP ACPRK ADBBV ADEZE ADMUD ADVLN AEFWE AEKER AENEX AEVXI AEXQZ AFCTW AFETI AFFNX AFRAH AFRHN AFTJW AGHFR AGYEJ AHMBA AITUG AJOXV AJRQY AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AZFZN BAWUL BENPR BLXMC BPHCQ CS3 DIK DU5 E3Z EBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FNPLU G-Q GBLVA GX1 H13 HVGLF HX~ HZ~ IHE IXB J1W J5H K-O KQ8 L7B MO0 N4W N9A NCXOZ O-L O9- OA. OAUVE OK1 OL~ OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 QTD R2- RIG ROL RPZ SCC SDF SDG SDP SES SEW SSZ T5K TR2 UNMZH UV1 W8F WH7 WOQ WOW X7M XPP YYM YYP YZZ Z5R ZGI ZXP AAIAV EFLBG LCYCR NAHTW ZA5 08R AAUGY AKALU IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 7TK H94 K9. NAPCQ 7X8 |
ID | FETCH-LOGICAL-c534t-e598f4f5f037118c615b469b10f7a775451856577d19c88edbe26a7fee0a65f33 |
IEDL.DBID | IXB |
ISSN | 0735-1097 |
IngestDate | Fri Aug 16 00:51:54 EDT 2024 Thu Oct 10 22:57:54 EDT 2024 Thu Sep 12 17:30:33 EDT 2024 Tue Oct 15 23:38:08 EDT 2024 Sun Oct 22 16:05:49 EDT 2023 Fri Feb 23 02:26:30 EST 2024 Tue Oct 15 22:53:21 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 13 |
Keywords | NO nitric oxide REPAIR-AMI trial bone marrow mononuclear progenitor cell myocardial infarction LVEF progenitor cells stromal cell-derived factor LV FACS red blood cell (erythrocyte) left ventricular ejection fraction RBC CFU SDF fluorescent-activated cell sorting BMC colony-forming unit left ventricle/ventricular AMI acute myocardial infarction Mononuclear cell Treatment Efficiency Red blood cell Bone marrow Product Autologous system Circulatory system Cardiology Cell Contamination |
Language | English |
License | http://www.elsevier.com/open-access/userlicense/1.0 CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c534t-e598f4f5f037118c615b469b10f7a775451856577d19c88edbe26a7fee0a65f33 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-News-1 ObjectType-Feature-3 content type line 23 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S0735109710002767 |
PMID | 20338501 |
PQID | 1506266874 |
PQPubID | 2031078 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_733835316 proquest_journals_1506266874 crossref_primary_10_1016_j_jacc_2009_10_059 pubmed_primary_20338501 pascalfrancis_primary_22635997 elsevier_sciencedirect_doi_10_1016_j_jacc_2009_10_059 elsevier_clinicalkeyesjournals_1_s2_0_S0735109710002767 |
PublicationCentury | 2000 |
PublicationDate | 2010-03-30 |
PublicationDateYYYYMMDD | 2010-03-30 |
PublicationDate_xml | – month: 03 year: 2010 text: 2010-03-30 day: 30 |
PublicationDecade | 2010 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States – name: New York |
PublicationTitle | Journal of the American College of Cardiology |
PublicationTitleAlternate | J Am Coll Cardiol |
PublicationYear | 2010 |
Publisher | Elsevier Inc Elsevier Elsevier Limited |
Publisher_xml | – name: Elsevier Inc – name: Elsevier – name: Elsevier Limited |
References | Anversa, Leri, Kajstura (bib6) 2006; 47 Pfeffer, McMurray, Velazquez (bib2) 2003; 349 Penn (bib5) 2006; 367 Meguro, Chen, Parent, Zhang (bib35) 2001; 32 Dimmeler, Leri (bib9) 2008; 102 Prozorovski, Schulze-Topphoff, Glumm (bib31) 2008; 10 Pitt, Remme, Zannad (bib1) 2003; 348 Mulder, Visser (bib33) 1987; 15 Assmus, Honold, Schachinger (bib19) 2006; 355 Kim, Cooper, Hayes, Spangrude (bib32) 1998; 91 Schächinger, Erbs, Elsässer (bib14) 2006; 355 Box, Cox (bib22) 1964; 26 Seeger, Tonn, Krzossok, Zeiher, Dimmeler (bib17) 2007; 28 Aicher, Heeschen, Mildner-Rihm (bib36) 2003; 9 Spyridopoulos, Fichtlscherer, Popp (bib24) 2008; 28 Quintero, Colombo, Godfrey, Moncada (bib29) 2006; 103 Sutherland, Anderson, Keeney, Nayar, Chin-Yee (bib20) 1996; 5 Britten, Abolmaali, Assmus (bib12) 2003; 108 Abdel-Latif, Bolli, Tleyjeh (bib7) 2007; 167 Mujoo, Sharin, Bryan (bib38) 2008; 105 Nesti, Pasquali, Vaglini, Siciliano, Murri (bib23) 2007; 27 Schächinger, Tonn, Dimmeler, Zeiher (bib16) 2006; 3 Kumar, Bandyopadhyay (bib26) 2005; 157 Schächinger, Erbs, Elsässer (bib15) 2006; 27 Hammond, Sharpless (bib10) 2008; 135 Martin-Rendon, Brunskill, Hyde, Stanworth, Mathur, Watt (bib28) 2008; 29 Hare, Chaparro (bib4) 2008; 13 Assmus, Fischer-Rasokat, Honold (bib18) 2007; 100 Chavakis, Carmona, Urbich (bib21) 2008; 102 Heeschen, Lehmann, Honold (bib13) 2004; 109 Dimmeler, Burchfield, Zeiher (bib3) 2008; 28 Marsboom, Pokreisz, Gheysens (bib34) 2008; 26 Vasa, Fichtlscherer, Aicher (bib11) 2001; 89 Mantel, Broxmeyer (bib30) 2008; 15 Askari, Unzek, Popovic (bib27) 2003; 362 Laufs, Werner, Link (bib37) 2004; 109 Minamino, Komuro (bib8) 2008; 5 Knudson, Brown (bib25) 2008; 414 Iwakura, Shastry, Luedemann (bib39) 2006; 113 Kumar (10.1016/j.jacc.2009.10.059_bib26) 2005; 157 Assmus (10.1016/j.jacc.2009.10.059_bib19) 2006; 355 Dimmeler (10.1016/j.jacc.2009.10.059_bib9) 2008; 102 Chavakis (10.1016/j.jacc.2009.10.059_bib21) 2008; 102 Quintero (10.1016/j.jacc.2009.10.059_bib29) 2006; 103 Meguro (10.1016/j.jacc.2009.10.059_bib35) 2001; 32 Laufs (10.1016/j.jacc.2009.10.059_bib37) 2004; 109 Schächinger (10.1016/j.jacc.2009.10.059_bib14) 2006; 355 Nesti (10.1016/j.jacc.2009.10.059_bib23) 2007; 27 Mujoo (10.1016/j.jacc.2009.10.059_bib38) 2008; 105 Vasa (10.1016/j.jacc.2009.10.059_bib11) 2001; 89 Hare (10.1016/j.jacc.2009.10.059_bib4) 2008; 13 Iwakura (10.1016/j.jacc.2009.10.059_bib39) 2006; 113 Aicher (10.1016/j.jacc.2009.10.059_bib36) 2003; 9 Minamino (10.1016/j.jacc.2009.10.059_bib8) 2008; 5 Penn (10.1016/j.jacc.2009.10.059_bib5) 2006; 367 Kim (10.1016/j.jacc.2009.10.059_bib32) 1998; 91 Britten (10.1016/j.jacc.2009.10.059_bib12) 2003; 108 Sutherland (10.1016/j.jacc.2009.10.059_bib20) 1996; 5 Box (10.1016/j.jacc.2009.10.059_bib22) 1964; 26 Dimmeler (10.1016/j.jacc.2009.10.059_bib3) 2008; 28 Mantel (10.1016/j.jacc.2009.10.059_bib30) 2008; 15 Prozorovski (10.1016/j.jacc.2009.10.059_bib31) 2008; 10 Spyridopoulos (10.1016/j.jacc.2009.10.059_bib24) 2008; 28 Anversa (10.1016/j.jacc.2009.10.059_bib6) 2006; 47 Mulder (10.1016/j.jacc.2009.10.059_bib33) 1987; 15 Heeschen (10.1016/j.jacc.2009.10.059_bib13) 2004; 109 Schächinger (10.1016/j.jacc.2009.10.059_bib15) 2006; 27 Knudson (10.1016/j.jacc.2009.10.059_bib25) 2008; 414 Seeger (10.1016/j.jacc.2009.10.059_bib17) 2007; 28 Assmus (10.1016/j.jacc.2009.10.059_bib18) 2007; 100 Pfeffer (10.1016/j.jacc.2009.10.059_bib2) 2003; 349 Abdel-Latif (10.1016/j.jacc.2009.10.059_bib7) 2007; 167 Schächinger (10.1016/j.jacc.2009.10.059_bib16) 2006; 3 Pitt (10.1016/j.jacc.2009.10.059_bib1) 2003; 348 Hammond (10.1016/j.jacc.2009.10.059_bib10) 2008; 135 Askari (10.1016/j.jacc.2009.10.059_bib27) 2003; 362 Martin-Rendon (10.1016/j.jacc.2009.10.059_bib28) 2008; 29 Marsboom (10.1016/j.jacc.2009.10.059_bib34) 2008; 26 |
References_xml | – volume: 15 start-page: 99 year: 1987 end-page: 104 ident: bib33 article-title: Separation and functional analysis of bone marrow cells separated by rhodamine-123 fluorescence publication-title: Exp Hematol contributor: fullname: Visser – volume: 13 start-page: 536 year: 2008 end-page: 542 ident: bib4 article-title: Cardiac regeneration and stem cell therapy publication-title: Curr Opin Organ Transplant contributor: fullname: Chaparro – volume: 109 start-page: 220 year: 2004 end-page: 226 ident: bib37 article-title: Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis publication-title: Circulation contributor: fullname: Link – volume: 32 start-page: 561 year: 2001 end-page: 566 ident: bib35 article-title: Caspase inhibitors attenuate oxyhemoglobin-induced apoptosis in endothelial cells publication-title: Stroke contributor: fullname: Zhang – volume: 102 start-page: 942 year: 2008 end-page: 949 ident: bib21 article-title: Phosphatidylinositol-3-kinase-gamma is integral to homing functions of progenitor cells publication-title: Circ Res contributor: fullname: Urbich – volume: 28 start-page: 766 year: 2007 end-page: 772 ident: bib17 article-title: Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction publication-title: Eur Heart J contributor: fullname: Dimmeler – volume: 27 start-page: 165 year: 2007 end-page: 171 ident: bib23 article-title: The role of mitochondria in stem cell biology publication-title: Biosci Rep contributor: fullname: Murri – volume: 15 start-page: 326 year: 2008 end-page: 331 ident: bib30 article-title: Sirtuin 1, stem cells, aging, and stem cell aging publication-title: Curr Opin Hematol contributor: fullname: Broxmeyer – volume: 26 start-page: 1017 year: 2008 end-page: 1026 ident: bib34 article-title: Sustained endothelial progenitor cell dysfunction after chronic hypoxia-induced pulmonary hypertension publication-title: Stem Cells contributor: fullname: Gheysens – volume: 102 start-page: 1319 year: 2008 end-page: 1330 ident: bib9 article-title: Aging and disease as modifiers of efficacy of cell therapy publication-title: Circ Res contributor: fullname: Leri – volume: 9 start-page: 1370 year: 2003 end-page: 1376 ident: bib36 article-title: Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells publication-title: Nat Med contributor: fullname: Mildner-Rihm – volume: 28 start-page: 208 year: 2008 end-page: 216 ident: bib3 article-title: Cell-based therapy of myocardial infarction publication-title: Arterioscler Thromb Vasc Biol contributor: fullname: Zeiher – volume: 28 start-page: 1967 year: 2008 end-page: 1974 ident: bib24 article-title: Caffeine enhances endothelial repair by an AMPK-dependent mechanism publication-title: Arterioscler Thromb Vasc Biol contributor: fullname: Popp – volume: 367 start-page: 87 year: 2006 end-page: 88 ident: bib5 article-title: Stem-cell therapy after acute myocardial infarction: the focus should be on those at risk publication-title: Lancet contributor: fullname: Penn – volume: 5 start-page: 637 year: 2008 end-page: 648 ident: bib8 article-title: Vascular aging: insights from studies on cellular senescence, stem cell aging, and progeroid syndromes publication-title: Nat Clin Pract Cardiovasc Med contributor: fullname: Komuro – volume: 29 start-page: 1807 year: 2008 end-page: 1818 ident: bib28 article-title: Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review publication-title: Eur Heart J contributor: fullname: Watt – volume: 355 start-page: 1210 year: 2006 end-page: 1221 ident: bib14 article-title: Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction publication-title: N Engl J Med contributor: fullname: Elsässer – volume: 26 start-page: 211 year: 1964 end-page: 252 ident: bib22 article-title: An analysis of transformations publication-title: Journal of the Royal Statistical Society, Series B (Methodological) contributor: fullname: Cox – volume: 103 start-page: 5379 year: 2006 end-page: 5384 ident: bib29 article-title: Mitochondria as signaling organelles in the vascular endothelium publication-title: Proc Natl Acad Sci U S A contributor: fullname: Moncada – volume: 157 start-page: 175 year: 2005 end-page: 188 ident: bib26 article-title: Free heme toxicity and its detoxification systems in human publication-title: Toxicol Lett contributor: fullname: Bandyopadhyay – volume: 362 start-page: 697 year: 2003 end-page: 703 ident: bib27 article-title: Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy publication-title: Lancet contributor: fullname: Popovic – volume: 47 start-page: 1769 year: 2006 end-page: 1776 ident: bib6 article-title: Cardiac regeneration publication-title: J Am Coll Cardiol contributor: fullname: Kajstura – volume: 167 start-page: 989 year: 2007 end-page: 997 ident: bib7 article-title: Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis publication-title: Arch Intern Med contributor: fullname: Tleyjeh – volume: 414 start-page: 95 year: 2008 end-page: 108 ident: bib25 article-title: Mitochondria potential, bax “activation,” and programmed cell death publication-title: Methods Mol Biol contributor: fullname: Brown – volume: 89 start-page: E1 year: 2001 end-page: E7 ident: bib11 article-title: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease publication-title: Circ Res contributor: fullname: Aicher – volume: 5 start-page: 213 year: 1996 end-page: 226 ident: bib20 article-title: The ISHAGE guidelines for CD34+ cell determination by flow cytometry publication-title: J Hematother contributor: fullname: Chin-Yee – volume: 3 start-page: S23 year: 2006 end-page: S28 ident: bib16 article-title: Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial publication-title: Nat Clin Pract Cardiovasc Med contributor: fullname: Zeiher – volume: 109 start-page: 1615 year: 2004 end-page: 1622 ident: bib13 article-title: Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease publication-title: Circulation contributor: fullname: Honold – volume: 27 start-page: 2775 year: 2006 end-page: 2783 ident: bib15 article-title: Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial publication-title: Eur Heart J contributor: fullname: Elsässer – volume: 113 start-page: 1605 year: 2006 end-page: 1614 ident: bib39 article-title: Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9 publication-title: Circulation contributor: fullname: Luedemann – volume: 348 start-page: 1309 year: 2003 end-page: 1321 ident: bib1 article-title: Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction publication-title: N Engl J Med contributor: fullname: Zannad – volume: 135 start-page: 1013 year: 2008 end-page: 1016 ident: bib10 article-title: HMGA2, microRNAs, and stem cell aging publication-title: Cell contributor: fullname: Sharpless – volume: 355 start-page: 1222 year: 2006 end-page: 1232 ident: bib19 article-title: Transcoronary transplantation of progenitor cells after myocardial infarction publication-title: N Engl J Med contributor: fullname: Schachinger – volume: 349 start-page: 1893 year: 2003 end-page: 1906 ident: bib2 article-title: Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both publication-title: N Engl J Med contributor: fullname: Velazquez – volume: 108 start-page: 2212 year: 2003 end-page: 2218 ident: bib12 article-title: Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging publication-title: Circulation contributor: fullname: Assmus – volume: 100 start-page: 1234 year: 2007 end-page: 1241 ident: bib18 article-title: Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry publication-title: Circ Res contributor: fullname: Honold – volume: 10 start-page: 385 year: 2008 end-page: 394 ident: bib31 article-title: Sirt1 contributes critically to the redox-dependent fate of neural progenitors publication-title: Nat Cell Biol contributor: fullname: Glumm – volume: 105 start-page: 18924 year: 2008 end-page: 18929 ident: bib38 article-title: Role of nitric oxide signaling components in differentiation of embryonic stem cells into myocardial cells publication-title: Proc Natl Acad Sci U S A contributor: fullname: Bryan – volume: 91 start-page: 4106 year: 1998 end-page: 4117 ident: bib32 article-title: Rhodamine-123 staining in hematopoietic stem cells of young mice indicates mitochondrial activation rather than dye efflux publication-title: Blood contributor: fullname: Spangrude – volume: 26 start-page: 211 year: 1964 ident: 10.1016/j.jacc.2009.10.059_bib22 article-title: An analysis of transformations publication-title: Journal of the Royal Statistical Society, Series B (Methodological) doi: 10.1111/j.2517-6161.1964.tb00553.x contributor: fullname: Box – volume: 105 start-page: 18924 year: 2008 ident: 10.1016/j.jacc.2009.10.059_bib38 article-title: Role of nitric oxide signaling components in differentiation of embryonic stem cells into myocardial cells publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0810230105 contributor: fullname: Mujoo – volume: 349 start-page: 1893 year: 2003 ident: 10.1016/j.jacc.2009.10.059_bib2 article-title: Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both publication-title: N Engl J Med doi: 10.1056/NEJMoa032292 contributor: fullname: Pfeffer – volume: 135 start-page: 1013 year: 2008 ident: 10.1016/j.jacc.2009.10.059_bib10 article-title: HMGA2, microRNAs, and stem cell aging publication-title: Cell doi: 10.1016/j.cell.2008.11.026 contributor: fullname: Hammond – volume: 9 start-page: 1370 year: 2003 ident: 10.1016/j.jacc.2009.10.059_bib36 article-title: Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells publication-title: Nat Med doi: 10.1038/nm948 contributor: fullname: Aicher – volume: 367 start-page: 87 year: 2006 ident: 10.1016/j.jacc.2009.10.059_bib5 article-title: Stem-cell therapy after acute myocardial infarction: the focus should be on those at risk publication-title: Lancet doi: 10.1016/S0140-6736(05)67895-6 contributor: fullname: Penn – volume: 103 start-page: 5379 year: 2006 ident: 10.1016/j.jacc.2009.10.059_bib29 article-title: Mitochondria as signaling organelles in the vascular endothelium publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0601026103 contributor: fullname: Quintero – volume: 113 start-page: 1605 year: 2006 ident: 10.1016/j.jacc.2009.10.059_bib39 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.105.553925 contributor: fullname: Iwakura – volume: 167 start-page: 989 year: 2007 ident: 10.1016/j.jacc.2009.10.059_bib7 article-title: Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis publication-title: Arch Intern Med doi: 10.1001/archinte.167.10.989 contributor: fullname: Abdel-Latif – volume: 47 start-page: 1769 year: 2006 ident: 10.1016/j.jacc.2009.10.059_bib6 article-title: Cardiac regeneration publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2006.02.003 contributor: fullname: Anversa – volume: 10 start-page: 385 year: 2008 ident: 10.1016/j.jacc.2009.10.059_bib31 article-title: Sirt1 contributes critically to the redox-dependent fate of neural progenitors publication-title: Nat Cell Biol doi: 10.1038/ncb1700 contributor: fullname: Prozorovski – volume: 15 start-page: 326 year: 2008 ident: 10.1016/j.jacc.2009.10.059_bib30 article-title: Sirtuin 1, stem cells, aging, and stem cell aging publication-title: Curr Opin Hematol doi: 10.1097/MOH.0b013e3283043819 contributor: fullname: Mantel – volume: 355 start-page: 1222 year: 2006 ident: 10.1016/j.jacc.2009.10.059_bib19 article-title: Transcoronary transplantation of progenitor cells after myocardial infarction publication-title: N Engl J Med doi: 10.1056/NEJMoa051779 contributor: fullname: Assmus – volume: 102 start-page: 1319 year: 2008 ident: 10.1016/j.jacc.2009.10.059_bib9 article-title: Aging and disease as modifiers of efficacy of cell therapy publication-title: Circ Res doi: 10.1161/CIRCRESAHA.108.175943 contributor: fullname: Dimmeler – volume: 28 start-page: 1967 year: 2008 ident: 10.1016/j.jacc.2009.10.059_bib24 article-title: Caffeine enhances endothelial repair by an AMPK-dependent mechanism publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.108.174060 contributor: fullname: Spyridopoulos – volume: 108 start-page: 2212 year: 2003 ident: 10.1016/j.jacc.2009.10.059_bib12 article-title: Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging publication-title: Circulation doi: 10.1161/01.CIR.0000095788.78169.AF contributor: fullname: Britten – volume: 5 start-page: 637 year: 2008 ident: 10.1016/j.jacc.2009.10.059_bib8 article-title: Vascular aging: insights from studies on cellular senescence, stem cell aging, and progeroid syndromes publication-title: Nat Clin Pract Cardiovasc Med doi: 10.1038/ncpcardio1324 contributor: fullname: Minamino – volume: 26 start-page: 1017 year: 2008 ident: 10.1016/j.jacc.2009.10.059_bib34 article-title: Sustained endothelial progenitor cell dysfunction after chronic hypoxia-induced pulmonary hypertension publication-title: Stem Cells doi: 10.1634/stemcells.2007-0562 contributor: fullname: Marsboom – volume: 27 start-page: 165 year: 2007 ident: 10.1016/j.jacc.2009.10.059_bib23 article-title: The role of mitochondria in stem cell biology publication-title: Biosci Rep doi: 10.1007/s10540-007-9044-1 contributor: fullname: Nesti – volume: 157 start-page: 175 year: 2005 ident: 10.1016/j.jacc.2009.10.059_bib26 article-title: Free heme toxicity and its detoxification systems in human publication-title: Toxicol Lett doi: 10.1016/j.toxlet.2005.03.004 contributor: fullname: Kumar – volume: 109 start-page: 1615 year: 2004 ident: 10.1016/j.jacc.2009.10.059_bib13 article-title: Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease publication-title: Circulation doi: 10.1161/01.CIR.0000124476.32871.E3 contributor: fullname: Heeschen – volume: 355 start-page: 1210 year: 2006 ident: 10.1016/j.jacc.2009.10.059_bib14 article-title: Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction publication-title: N Engl J Med doi: 10.1056/NEJMoa060186 contributor: fullname: Schächinger – volume: 28 start-page: 766 year: 2007 ident: 10.1016/j.jacc.2009.10.059_bib17 article-title: Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction publication-title: Eur Heart J doi: 10.1093/eurheartj/ehl509 contributor: fullname: Seeger – volume: 109 start-page: 220 year: 2004 ident: 10.1016/j.jacc.2009.10.059_bib37 article-title: Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis publication-title: Circulation doi: 10.1161/01.CIR.0000109141.48980.37 contributor: fullname: Laufs – volume: 32 start-page: 561 year: 2001 ident: 10.1016/j.jacc.2009.10.059_bib35 article-title: Caspase inhibitors attenuate oxyhemoglobin-induced apoptosis in endothelial cells publication-title: Stroke doi: 10.1161/01.STR.32.2.561 contributor: fullname: Meguro – volume: 28 start-page: 208 year: 2008 ident: 10.1016/j.jacc.2009.10.059_bib3 article-title: Cell-based therapy of myocardial infarction publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.107.155317 contributor: fullname: Dimmeler – volume: 348 start-page: 1309 year: 2003 ident: 10.1016/j.jacc.2009.10.059_bib1 article-title: Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction publication-title: N Engl J Med doi: 10.1056/NEJMoa030207 contributor: fullname: Pitt – volume: 89 start-page: E1 year: 2001 ident: 10.1016/j.jacc.2009.10.059_bib11 article-title: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease publication-title: Circ Res doi: 10.1161/hh1301.093953 contributor: fullname: Vasa – volume: 100 start-page: 1234 year: 2007 ident: 10.1016/j.jacc.2009.10.059_bib18 article-title: Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry publication-title: Circ Res doi: 10.1161/01.RES.0000264508.47717.6b contributor: fullname: Assmus – volume: 414 start-page: 95 year: 2008 ident: 10.1016/j.jacc.2009.10.059_bib25 article-title: Mitochondria potential, bax “activation,” and programmed cell death publication-title: Methods Mol Biol contributor: fullname: Knudson – volume: 3 start-page: S23 issue: Suppl 1 year: 2006 ident: 10.1016/j.jacc.2009.10.059_bib16 article-title: Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial publication-title: Nat Clin Pract Cardiovasc Med doi: 10.1038/ncpcardio0441 contributor: fullname: Schächinger – volume: 5 start-page: 213 year: 1996 ident: 10.1016/j.jacc.2009.10.059_bib20 article-title: The ISHAGE guidelines for CD34+ cell determination by flow cytometry publication-title: J Hematother doi: 10.1089/scd.1.1996.5.213 contributor: fullname: Sutherland – volume: 102 start-page: 942 year: 2008 ident: 10.1016/j.jacc.2009.10.059_bib21 article-title: Phosphatidylinositol-3-kinase-gamma is integral to homing functions of progenitor cells publication-title: Circ Res doi: 10.1161/CIRCRESAHA.107.164376 contributor: fullname: Chavakis – volume: 91 start-page: 4106 year: 1998 ident: 10.1016/j.jacc.2009.10.059_bib32 article-title: Rhodamine-123 staining in hematopoietic stem cells of young mice indicates mitochondrial activation rather than dye efflux publication-title: Blood doi: 10.1182/blood.V91.11.4106 contributor: fullname: Kim – volume: 29 start-page: 1807 year: 2008 ident: 10.1016/j.jacc.2009.10.059_bib28 article-title: Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review publication-title: Eur Heart J doi: 10.1093/eurheartj/ehn220 contributor: fullname: Martin-Rendon – volume: 13 start-page: 536 year: 2008 ident: 10.1016/j.jacc.2009.10.059_bib4 article-title: Cardiac regeneration and stem cell therapy publication-title: Curr Opin Organ Transplant doi: 10.1097/MOT.0b013e32830fdfc4 contributor: fullname: Hare – volume: 27 start-page: 2775 year: 2006 ident: 10.1016/j.jacc.2009.10.059_bib15 article-title: Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial publication-title: Eur Heart J doi: 10.1093/eurheartj/ehl388 contributor: fullname: Schächinger – volume: 15 start-page: 99 year: 1987 ident: 10.1016/j.jacc.2009.10.059_bib33 article-title: Separation and functional analysis of bone marrow cells separated by rhodamine-123 fluorescence publication-title: Exp Hematol contributor: fullname: Mulder – volume: 362 start-page: 697 year: 2003 ident: 10.1016/j.jacc.2009.10.059_bib27 article-title: Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy publication-title: Lancet doi: 10.1016/S0140-6736(03)14232-8 contributor: fullname: Askari |
SSID | ssj0006819 |
Score | 2.3441782 |
Snippet | Objectives The aim of this study was to identify an association between the quality and functional activity of bone marrow-derived progenitor cells (BMCs) used... The aim of this study was to identify an association between the quality and functional activity of bone marrow-derived progenitor cells (BMCs) used for... OBJECTIVESThe aim of this study was to identify an association between the quality and functional activity of bone marrow-derived progenitor cells (BMCs) used... |
SourceID | proquest crossref pubmed pascalfrancis elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1385 |
SubjectTerms | Animals Biological and medical sciences Bone marrow Bone Marrow Transplantation - methods Cardiology Cardiology. Vascular system Cardiovascular Cell Count Cell Separation - methods Cell Separation - standards Cell Survival Disease Models, Animal Erythrocytes Heart attacks Hindlimb - blood supply Humans Internal Medicine Ischemia - therapy Medical sciences Mice Mice, Inbred BALB C Mice, Nude Multivariate Analysis Myocardial Contraction - physiology myocardial infarction Myocardial Infarction - therapy progenitor cells Quality Control REPAIR-AMI trial Stem Cell Transplantation Stem cells Stroke Volume Studies Treatment Outcome |
Title | Red Blood Cell Contamination of the Final Cell Product Impairs the Efficacy of Autologous Bone Marrow Mononuclear Cell Therapy |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0735109710002767 https://dx.doi.org/10.1016/j.jacc.2009.10.059 https://www.ncbi.nlm.nih.gov/pubmed/20338501 https://www.proquest.com/docview/1506266874 https://search.proquest.com/docview/733835316 |
Volume | 55 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDCa6DhgGFMPec9cGOuw2eLEtS5aPSdCie3QYtnbITZBlCUgRJEGcHHrpby9p2SmKbT3sKuoFkaJok_wI8KHyeJuVreLcuCzOleOxwZa44nVSC264tG20xXd5dpl_mYrpHkz6XBgKq-x0f9DprbbuWobdaQ5Xs9nwFwqnIP9p2rrPJGWUE7YnJfFNxzttLFVb3IM6x9S7S5wJMV5XxtqAWUkRXoRX-vfH6WBlGjwyH2pd_NsYbR-l0-fwrLMm2Shs-AXsucVLeHLe-ctfwc1PV7MxxaaziZvPGWFRGQp-IXawpWdo_jEq0TsP9B8B_5V9RiUxWzct-YRAJoy9pu6jbVvudrlt2Hi5cOy8hXBkqBiWCwJGNuswz0XAKngNl6cnF5OzuKu4EFvB803sRKl87oUnIL9UWTR3Kvx-rtLEF4aw8gQ-71IURZ2WVilXVy6TpvDOJUYKz_kb2McF3Ttg3GS-xmE8VzavTa28zGwpTUJ-WZeaCD72R61XAVhD9xFnV5oYQxUyS2pDxkRQ9NzQfcooKjnXdDeu0aluMp3oP6QiArEbeU-wNL4ZD644uMf03SYzgu8pS5z4qJcCfbcLkeAXolRFHgHbkfHGkhvGLBzyRxf0VwBVn4zgbRCeu7kTpIkkPfzPTb-HpyG6gcc8OYL9zXrrjtFo2lQDePTpJh3A49H499dvg_aO3AIhxRaZ |
link.rule.ids | 315,786,790,3525,4521,27600,27955,27956,45618,45696,45907 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Na9swFH90HWyDMfY9b12nw27DxLYsWT42oSXdmjK2FHITsixBSkhCnBx66d--9yw7pezjsKu-LPQ-5ff0ewCfK4_SrGwV58Zlca4cjw22xBWvk1pww6Vtsy0u5fgq_zoTswMY9W9hKK2y0_1Bp7faumsZdKc5WM_ng5_InILip2kbPpPFA3iYC7zr0Su-2XCvjqVqq3vQ6JiGdy9nQpLXtbE2gFZSihcBlv7ZOj1dmwbPzIdiF3_3RlurdPYcnnXuJDsJO34BB275Eh5NuoD5K7j94Wo2pOR0NnKLBSMwKkPZL0QPtvIM_T9GNXoXof97AIBl56gl5pum7T4llAljb2j4ya6td7vaNWy4Wjo2aTEcGWqG1ZKQkc0mrDMNYAWv4ersdDoax13JhdgKnm9jJ0rlcy88IfmlyqK_U-EFukoTXxgCyxNo36UoijotrVKurlwmTeGdS4wUnvM3cIgfdO-AcZP5GqfxXNm8NrXyMrOlNAkFZl1qIvjSH7VeB2QN3aecXWsiDJXILKkNCRNB0VND929GUcu5phO5Rqe6yXSif2OLCMR-5j3O0mg0_vnF43tE328yI_yessSFj3ou0He7EAleEaUq8gjYvhtFluIwZumQPrqg3wKo-2QEbwPz3K2dYJ9I0vf_uelP8Hg8nVzoi_PLbx_gSUh14DFPjuBwu9m5j-hBbavjVkJ-AeloFy0 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Red+Blood+Cell+Contamination+of+the+Final+Cell+Product+Impairs+the+Efficacy+of+Autologous+Bone+Marrow+Mononuclear+Cell+Therapy&rft.jtitle=Journal+of+the+American+College+of+Cardiology&rft.au=Assmus%2C+Birgit&rft.au=Tonn%2C+Torsten&rft.au=Seeger%2C+Florian+H.&rft.au=Yoon%2C+Chang-Hwan&rft.date=2010-03-30&rft.pub=Elsevier+Inc&rft.issn=0735-1097&rft.eissn=1558-3597&rft.volume=55&rft.issue=13&rft.spage=1385&rft.epage=1394&rft_id=info:doi/10.1016%2Fj.jacc.2009.10.059&rft.externalDocID=S0735109710002767 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F07351097%2FS0735109710X00109%2Fcov150h.gif |